Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

4.620 +0.270 (+6.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7... 
Via Benzinga
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive. 
Via Talk Markets
MindMed Stock Climbs In Nasdaq Debut As Psychedelics Follow Pot's Path To Mainstream
MindMed stock rose in its Nasdaq listing debut on Tuesday, making it the latest psychedelic drug developer to land on a major U.S. exchange. 
Via Investor's Business Daily
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week 
Via Benzinga
Topics Cannabis
Exposures Cannabis
How This Psychedelic Company Could Lead A Turnaround For The Sector
Compass Pathways PLC (NASDAQ:CMPS) is often viewed as the leader in the psychedeli... 
Via Benzinga
Majority Of Pure-Play Psychedelic Drug Stocks Went Up Last Week
41 psychedelic drug stocks trade on the various North American stock exchanges and in the past week 24 went up, 12 went down and 5 had no change in price. 
Via Talk Markets
Psyched: MindMed, Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Resumes Trading
Two of the most highly funded companies in the psychedelics space announced plans last week to list on the Nasdaq exchange. Months after ... 
Via Benzinga
With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted
Via FinancialNewsMedia
Déjà Vu: 2021 Slump In Psychedelic Stocks Mirrors 2020
Charts for most psychedelic drug stocks look terrible in recent weeks. The same was true in the summer of 2020 -- immediately before these stocks exploded higher. Deja vu? 
Via Talk Markets
Psychedelic Stocks: Atai Life Sciences IPO Seeks To Raise $100 Million
Atai Life Sciences hopes to raise $100 million in an initial public offering, as other psychedelic stocks seek investor cash. 
Via Investor's Business Daily
Topics Initial Public Offering
Exposures Securities Market
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: California Psychedelics Bill Passes Second Committee, GH Research Closes $125M Series B, Study Shows Psilocybin Could Equal SSRI Results In Depression
A bill that would remove penalties for the possession, personal use and social sharing of certain natural and synthetic psychedelics in Califo... 
Via Benzinga
Pure-Play Psychedelic Drug Stocks Index Declined 5.7% This Week
In the past week, of the 41 psychedelic drug stocks that trade on the various North American stock exchanges only nine went up, in price while 31 went down and one had no change. 
Via Talk Markets
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Biotech Companies Driving Psychedelics Industry Forward with Key Research
Via FinancialNewsMedia
Psychedelic Stocks Primed For Atai-MindMed Bounce
It's now looking like the atai Life Sciences IPO and the MindMed uplisting to the Nasdaq could occur within weeks of each other. We point out what that means for investors in psychedelic stocks. 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.